Keyphrases
Autoimmune Neutropenia
75%
Biocomputing
24%
Clinical Concerns
24%
Control Value
24%
Deceased Donor
24%
Demosponges
75%
Diagnostic Laboratory
24%
Disease Association
24%
DPA1
24%
DPB1
24%
DQA1
24%
DRB1
100%
DRB3
24%
DRB4
24%
Early childhood
75%
Epigenetics
24%
Exon
24%
FCGR Locus
24%
Fcgr2b
75%
Flow Cell
24%
Free-living Bacteria
32%
Halichondria Panicea
75%
High-resolution
75%
High-resolution HLA Typing
24%
High-resolution Typing
24%
Histo-blood Group
75%
HLA Haplotypes
75%
HLA Typing
55%
HLA-A
24%
HLA-DQB1
100%
Human Leukocyte antigen-DRB1
75%
Human Neutrophil Antigens
75%
Large Amount of Data
24%
Multicenter Clinical Trial
24%
Nanopore Sequencing
75%
Next-generation Sequencing
50%
Novel Allele
75%
PCR-sequence Based Typing
45%
Predictiveness
75%
Quality Control
50%
Quality Control Data
24%
Quantitative PCR
24%
Rapid Evolution
24%
Reusability
24%
Sequence-specific Primers
45%
Solid Organ
24%
Stem Cell Transplantation
24%
Third-generation Sequencing Technology
75%
Tissue Type
24%
Typing Technique
24%
Immunology and Microbiology
ABO Blood Group System
37%
Allele
24%
Antibody Specificity
25%
Autoantibodies
87%
Blood Component
12%
Blood Group Lewis System
75%
Blood Group System
37%
Carbohydrate Antigen
37%
CD163
75%
Copy Number Variation
87%
Droplet Digital Polymerase Chain Reaction
24%
Dry Weight
56%
Enzyme-Linked Immunosorbent Assay
6%
Epigenetics
24%
Exon
24%
Fc Receptor
12%
FCGR2B
75%
FCGR3A
12%
FCGR3B
75%
FOXP3
75%
Genetic Polymorphism
75%
Genetic Risk
75%
Genetic Variability
50%
Genome-Wide Association Study
37%
Genotype
75%
Halichondria
75%
Haplotype
37%
HLA Typing
75%
Human Leukocyte Antigen
75%
ICD-10
37%
Monospecific Antibody
24%
Multiplex Ligation Dependent Probe Amplification
18%
Neutrophil
25%
Neutrophil Granulocyte
12%
Next Generation Sequencing
50%
Normal Human
13%
Overall Survival
6%
Polymerase Chain Reaction
75%
Real Time Polymerase Chain Reaction
37%
Real-Time Polymerase Chain Reaction
75%
Regulatory T Cell
62%
Sample Size
37%
Sensitization
37%
Single Nucleotide Polymorphism
50%
Stem Cell Transplantation
24%
Survival Rate
6%
Tissue Typing
24%
Medicine and Dentistry
Allele
75%
Antibody Specificity
15%
Autoimmune neutropenia
75%
Biological Marker
9%
Blood Group Antigen
37%
Blood Group Lewis System
75%
Blood Group System
37%
Carbohydrate Antigen
37%
Diagnosis
37%
Diseases
30%
Endometriosis
75%
Enzyme Linked Immunosorbent Assay
9%
Epitope
45%
Gene Frequency
15%
Genetic Risk
10%
Genetic Variability
5%
Genome Wide Association Study
5%
Genotype
75%
Haplotype
45%
Health Care
5%
HLA Typing
15%
HLA-A
15%
HLA-DRB1
15%
ICD-10
5%
Laparoscopy
5%
Multivariate Analysis
9%
Odds Ratio
37%
Overall Survival
9%
Pancreas Adenocarcinoma
75%
Patient Referral
5%
Patient Registry
5%
Proportional Hazards Model
9%
Risk Stratification
5%
Sensitization
5%
Survival Rate
9%
Symptom
5%
UK Biobank
16%
Univariate Analysis
9%
